Major pharmaceutical firms' earnings improving

Leading drug makers have seen their earnings improve steadily in the January-September period due to profit-oriented management strategies instead of expanding sales, according to pharmaceutical business sources.

These companies listed on the main bourse - Korea Stock Exchange have focused on more stable growth in sales and net profits without risk management, with more emphasis on their fl...